SHL Medical’s new facility in South Carolina marks a major milestone in the global biopharma supply chain, enhancing access to life-saving autoinjector technologies. The investment not only reinforces the company’s leadership in drug delivery systems but also strengthens the U.S. manufacturing ecosystem with sustainable practices and robust job creation. As chronic conditions requiring self-injection therapies rise, this expansion ensures SHL Medical remains at the forefront of healthcare innovation and delivery.